Tendee LogoChatBlog
Public Tender Opportunity

Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - POLATUZUMAB VEDOTINA [30 MG; PÓ CONC SOL INJ; FRS]

Published on July 15, 2025

Tender Description

POLATUZUMAB VEDOTINA [30 MG; PÓ CONC SOL INJ; FRS]

Unlock Full Tender Insight

Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.

It's free to get started. No credit card required.